Never Miss a Biotech Catalyst
Track PDUFA dates, Phase 3 results, and FDA decisions for 1,729+ biotech stocks — every date confidence-rated (confirmed, estimated, or AI-detected) so you know how solid it is.
Catalyst Activity
Upcoming events and recent outcomes
Upcoming
Learn Biotech Investing
Master biotech fundamentals with our structured academy. 12 modules covering FDA regulation, clinical trials, gene therapy, oncology, M&A, and more — with interactive quizzes and real-world scenarios.
FDA & Regulation
8 lessons
Clinical Trials
8 lessons
Market Dynamics
8 lessons
M&A & IPO
9 lessons
Latest Biotech News
Recent headlines from the biotech sector
Start Trading Smarter
Join biotech investors using AI-powered predictions to time their entries. Free tier available, upgrade anytime for ML predictions and alerts.
Official Sources
Real-time Sync
Free + Pro
The biotech catalyst calendar, built for investors
CatalystAlert is a biotech catalyst calendar that tracks every market-moving event for 1,729+ biopharma companies — FDA PDUFA decision dates, Phase 3 trial readouts, FDA advisory committee meetings, and every other catalyst type. Each date is confidence-rated — confirmed against an official regulatory source, estimated, or AI-detected — so you always know how firm a biopharmaceutical catalyst really is. Check this week's catalysts or the signal-ranked Catalyst Radar to see what's coming next.
Frequently asked questions
What is CatalystAlert?
CatalystAlert is a biotech catalyst tracking platform with AI-powered predictions that helps investors monitor PDUFA dates, clinical trial results, FDA decisions, and predict stock price movements for 1,600+ biotechnology companies.
How much does CatalystAlert cost?
CatalystAlert offers a free tier with a 7-day catalyst calendar view, company search and a watchlist. Pro is $29.99/mo and unlocks the full calendar horizon plus AI predictions and alerts — and starts with a 48-hour free trial (card required; cancel anytime before it ends and you are not charged). Elite tier ($99.99/mo) coming soon with API access.
Where does CatalystAlert get its data?
CatalystAlert aggregates data from official sources including ClinicalTrials.gov, SEC EDGAR filings, FDA openFDA database, EMA, and company press releases. Our ML models are trained on historical catalyst outcomes with price data — see our public track record for how they have actually performed.
What types of biotech catalysts are tracked?
We track PDUFA dates, Phase 1/2/3 clinical trial results, FDA Advisory Committee meetings (AdCom), NDA/BLA filings, earnings reports, conference presentations, EMA approvals, and other regulatory events worldwide.
How does CatalystAlert analyze catalysts?
We analyze catalyst characteristics, therapeutic area, clinical phase, FDA designations, historical patterns, and market conditions to help you understand potential stock price impacts. Our data-driven approach combines multiple factors for comprehensive catalyst analysis.
What is Likelihood of Approval (LOA)?
LOA is a probability score predicting the chance of FDA approval for a drug based on its phase, therapeutic area, trial design, and special designations like Breakthrough Therapy or Fast Track. Our Logistic Regression model is calibrated against BIO industry benchmarks.
How often is the data updated?
Core data syncs every 2-6 hours from official government databases. ML models are retrained weekly with new outcomes. Real-time alerts notify subscribers within minutes of major announcements.
Can I get alerts for specific catalysts?
Yes! Create a watchlist of companies you follow and enable push notifications to receive instant alerts when catalysts approach, results are announced, or significant price movements occur.
CatalystAlert is an informational platform only and does NOT provide financial advice. All predictions are based on historical data and are not guarantees of future results. Biotech investing carries significant risk including potential total loss of investment. Always consult a qualified financial advisor. Full Terms